The Food and Drug Administration has granted approval to AliveCor for its smartphone-based atrial fibrillation detection algorithm.

The company says the algorithm instantly detects if patients are experiencing AFib through real-time electrocardiogram recordings taken on a mobile phone-based AliveCor Heart Monitor, so physicians can intervene before potentially life-threatening conditions, like strokes, occur. Through AliveCor’s ECG analysis service, patients can confirm their results with a U.S. board-certified cardiologist or a personal physician.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access